You are here

Ilaris

Novartis hits another setback in plan to repurpose rare disease drug in lung cancer

BioPharma Dive

Mon, 10/25/21 - 11:51 pm

clinical trials

Novartis’ Ilaris fails in late-stage COVID-19 trial

Pharmaforum

Fri, 11/6/20 - 09:59 am

clinical trials

Novartis’ Ilaris unexpectedly slashes need for joint replacements from osteoarthritis in key study

Fierce Biotech

Mon, 08/3/20 - 11:45 pm

joint replacements

ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster

Fierce Pharma

Tue, 08/29/17 - 11:05 am

Novartis shares slip after mixed heart drug data

Yahoo/Reuters

Mon, 08/28/17 - 09:33 am

cardiovascular disease

Drugmakers face challenges marketing new heart drugs

Medical Marketing and Media

Sat, 07/22/17 - 10:01 am

Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

Forbes

Thu, 06/22/17 - 09:53 am

Second FDA thumbs-up for Novartis Ilaris

Pharma Times, UK

Fri, 05/10/13 - 08:59 am

systemic juvenile idiopathic arthritis

Novartis touts new data on Certican, Ilaris

Fierce Pharma

Mon, 11/12/12 - 12:28 pm

Novartis drug helps in severe childhood arthritis

Reuters

Mon, 11/7/11 - 12:05 pm

juvenile arthritis

systemic juvenile idiopathic arthritis

FDA asks Novartis for more data on gout drug

Reuters

Mon, 08/29/11 - 01:11 pm

FDA Is Urged To Suspend Trials Of Novartis Drug

Pharmalot

Tue, 07/19/11 - 01:01 pm

FDA votes against Novartis gout drug: WSJ

Marketwatch

Wed, 06/22/11 - 09:03 am

advisory panels

US FDA staff-Novartis gout drug data 'complicated'

Reuters

Fri, 06/17/11 - 12:22 pm

Novartis Says Experimental Gout Drug is Effective

WSJ Online

Wed, 05/25/11 - 09:21 am

A Meaningless FDA Approval ... for Now

Motley Fool

Sat, 06/20/09 - 09:30 am

The FDA O.K.'s Novartis' Ilaris

Businessweek

Fri, 06/19/09 - 08:59 am

autoimmune disease

Novartis says Ilaris gets FDA approval for CAPS

Marketwatch

Thu, 06/18/09 - 08:02 am